Literature DB >> 9041091

Effects of phacoemulsification time on the corneal endothelium using phacofracture and phaco chop techniques.

G Pirazzoli1, D D'Eliseo, M Ziosi, R Acciarri.   

Abstract

PURPOSE: To quantitatively assess early postoperative endothelial damage caused by two phacoemulsification techniques and to ascertain the effect of differences in phacoemulsification time.
SETTING: Department of Ophthalmology, Umberto Hospital, Lugo, Italy.
METHODS: This prospective study evaluated 100 patients who had phacoemulsification using one of two techniques: phaco chop (n = 50) or four-quadrant, divide and conquer phacofracture (n = 50). The endothelium of both groups was analyzed preoperatively and 8 weeks postoperatively by specular microscopy.
RESULTS: Phaco chop led to significantly shorter phacoemulsification time and less endothelial damage. Mean equivalent phacoemulsification time was 25.53 seconds +/- 11.26 (SD) in the phaco chop group and 87.26 +/- 48.03 seconds in the phacofracture group. Endothelial cell loss was 4.72 +/- 1.2% and 13.80 +/- 4.3%, respectively.
CONCLUSION: The phaco chop technique led to shorter phacoemulsification time and less endothelial cell loss.

Entities:  

Mesh:

Year:  1996        PMID: 9041091     DOI: 10.1016/s0886-3350(96)80200-8

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  16 in total

1.  Comparing surgical efficiencies between phacoemulsification systems: a single surgeon retrospective study of 2000 eyes.

Authors:  Luis Escaf-Jaraba; Jorge Escobar-DiazGranados; Bartolomé Valdemarín
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

2.  Comparison of CDE data in phacoemulsification between an open hospital-based ambulatory surgical center and a free-standing ambulatory surgical center.

Authors:  Ming Chen; Mindy Chen
Journal:  Clin Ophthalmol       Date:  2010-11-12

3.  Phaco Prechop versus Divide and Conquer Phacoemulsification: A Prospective Comparative Interventional Study.

Authors:  Effat A Elnaby; Omar M El Zawahry; Ahmed M Abdelrahman; Hany E Ibrahim
Journal:  Middle East Afr J Ophthalmol       Date:  2008-07

4.  Safety, efficacy, and intraoperative characteristics of DisCoVisc and Healon ophthalmic viscosurgical devices for cataract surgery.

Authors:  Satish S Modi; James A Davison; Tom Walters
Journal:  Clin Ophthalmol       Date:  2011-09-23

5.  Comparison of corneal endothelial cell loss during phacoemulsification using continuous anterior chamber infusion versus those using ophthalmic viscosurgical device: randomized controlled trial.

Authors:  B K Nayak; Elesh Kumar Jain
Journal:  Indian J Ophthalmol       Date:  2009 Mar-Apr       Impact factor: 1.848

6.  A retrospective randomized study to compare the energy delivered using CDE with different techniques and OZil settings by different surgeons in phacoemulsification.

Authors:  Ming Chen; Henry W Sweeney; Becky Luke; Mindy Chen; Mathew Brown
Journal:  Clin Ophthalmol       Date:  2009-07-14

7.  Comparison of cumulative dissipated energy between the Infiniti and Centurion phacoemulsification systems.

Authors:  Ming Chen; Erik Anderson; Geoffrey Hill; John J Chen; Thomas Patrianakos
Journal:  Clin Ophthalmol       Date:  2015-07-22

8.  Changes in corneal endothelium cell characteristics after cataract surgery with and without use of viscoelastic substances during intraocular lens implantation.

Authors:  Stephan D Schulze; Thomas Bertelmann; Irena Manojlovic; Stefan Bodanowitz; Sebastian Irle; Walter Sekundo
Journal:  Clin Ophthalmol       Date:  2015-11-06

9.  Evaluating the different laser fragmentation patterns used in laser cataract surgeries in terms of effective phacoemulsification time and power.

Authors:  Tukezban Huseynova; Mariko Mita; Christine Carole C Corpuz; Yuko Sotoyama; Minoru Tomita
Journal:  Clin Ophthalmol       Date:  2015-11-06

10.  Retinal thickness changes after phacoemulsification.

Authors:  Gede Pardianto; Nila Moeloek; Julia Reveny; Sutarman Wage; Imsyah Satari; Rosita Sembiring; Nuttamon Srisamran
Journal:  Clin Ophthalmol       Date:  2013-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.